[Table/Fig-6]:
Clinical Stages |
Male Total=39 |
Female Total=16 |
Total N=55 (%) |
Chi-square test statistics |
---|---|---|---|---|
Stage I | 2 | 3 | 5 (9.09) |
19.810 p-value<0.05 |
Stage II | 31 | 11 | 42 (76.3) |
|
Stage III | 6 | 2 | 8 (14.54) |
Clinical Stages |
Male Total=39 |
Female Total=16 |
Total N=55 (%) |
Chi-square test statistics |
---|---|---|---|---|
Stage I | 2 | 3 | 5 (9.09) |
19.810 p-value<0.05 |
Stage II | 31 | 11 | 42 (76.3) |
|
Stage III | 6 | 2 | 8 (14.54) |